Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.82
+1.07 (15.78%)
Mar 9, 2026, 3:22 PM EDT - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $608.87 million as of March 9, 2026. Its market cap has increased by 154.01% in one year.
Market Cap
608.87M
Enterprise Value
375.58M
1-Year Change
154.01%
Ranking
Category
Stock Price
$7.82
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $608.87M, a decrease of -19.26%. That is a compound annual growth rate of -2.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 525.90M | 19.69% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 544.12M |
| Rigel Pharmaceuticals | 533.32M |
| Ocugen | 527.91M |
| Contineum Therapeutics | 518.00M |
| Allogene Therapeutics | 516.88M |
| Prothena Corporation | 516.26M |
| Neumora Therapeutics | 513.21M |
| Forte Biosciences | 512.83M |